SCHEMBL6185980

SCHEMBL6185980

Cc1[nH]c2ccc(N)cc2c1C(=O)c1c(Cl)cccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
RAB9A P51151 3/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 3/20 0.41
NPC1 O15118 2/20 0.41
MAPK1 P28482 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
PKM P14618 1/20 0.41
NGFR P08138 1/20 0.40
MITF O75030 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GAA P10253 1/20 0.39
PARP1 P09874 1/20 0.39
ALOX15 P16050 1/20 0.39
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
NR4A2 P43354 1/20 0.38
FGFR1 P11362 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6188924 0.91 LMNA (0.39) LMNARAB9AMAPTALDH1A1NPC1
SCHEMBL6188992 0.84 ALDH1A1 (0.41) LMNARAB9AMAPTALDH1A1MAPK1
SCHEMBL6187040 0.83 NGFR (0.42) LMNARAB9AMAPTALDH1A1NPC1
SCHEMBL6191071 0.82 TUBB1 (0.44) LMNARAB9AMAPTALDH1A1NPC1
SCHEMBL6186570 0.80 ALDH1A1 (0.51) LMNARAB9AMAPTALDH1A1NPC1
SCHEMBL28358993 0.78 NGFR (0.46) LMNARAB9AMAPTALDH1A1MAPK1
SCHEMBL6185751 0.77 AR (0.45) MAPTALDH1A1SMN1; SMN2NGFRGAA
SCHEMBL6185825 0.77 TYK2 (0.45) LMNARAB9AMAPTALDH1A1NPC1
SCHEMBL6189327 0.76 HPGD (0.46) LMNAMAPTALDH1A1SMN1; SMN2HTT
SCHEMBL6185706 0.75 MAOB (0.42) LMNARAB9AMAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed